Q BioMed Inc. 'Q' is a biomedical acceleration and development company. We are focused on licensing and acquiring undervalued and under-appreciated biomedical assets. Q is dedicated to providing these target assets, the strategic resources, developmental support, and expansion capital to ensure they meet their potential. The end result being value recognition and ultimately enabling them to provide products to patients in need.
QBIO 4,01 -0,12 -2,91%
“Our vision is to create a pipeline of innovative biomedical assets in various stages of development in multiple therapeutic areas. Our strategy will minimize risk, share success and accelerate our assets’ technologies to monetization.”